A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates
about
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsImproving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsNew gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation.Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cellsOptimizing NKT cell ligands as vaccine adjuvantsSmall-Molecule Carbohydrate-Based Immunostimulants.Glycolipid activators of invariant NKT cells as vaccine adjuvants.Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.Development of a novel mechanism-based glycolipid adjuvant for vaccination.
P2860
Q26748456-C3F93A41-06A9-4A2F-9A76-0A212B5E2DFCQ28543248-6CD0C151-F802-49F4-90F9-0EC741F0A8D0Q33868760-C7706A02-D3CF-4104-B13A-F4F4A7A23FEDQ35837120-B835D541-B136-4DCF-A0D0-73C7779FAA31Q36031556-6F6D029F-ED79-48EA-A10C-7E97EF466B35Q37083610-47527E12-6D43-4711-90B9-7C5554D4E1BBQ38206819-9BF7B82C-6914-44BA-8ED8-987FB4B1E3F2Q38844616-C2CF5B53-B6E2-44A4-BEFE-73D110F6384DQ38885794-6A504429-882D-4760-A014-BB145537A6ECQ39196835-08540761-DFB0-4233-BF02-61ED9F46F7BCQ40500189-9033B1F1-1A27-4F2A-9727-5529630D81E9Q40832140-6ECC0E39-E2F3-41ED-A250-E86BE06B98A6Q47993724-84E46C82-7AB4-45F6-BD8C-EA3C06F6DE71Q55293243-4E1964A9-1AA5-409A-84B9-0B95065F96C3
P2860
A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@ast
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@en
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@nl
type
label
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@ast
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@en
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@nl
prefLabel
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@ast
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@en
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
A glycolipid adjuvant, 7DW8-5, ...... vaccine in non-human primates
@en
P2093
Agegnehu Gettie
Brooke F Grasperge
Chasity D Andrews
Chi-Huey Wong
David D Ho
Douglass Wu
Jenny McManus
Jordana G Coelho-dos-Reis
Joseph T Bruder
Mar Boente-Carrera
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0078407
P407
P577
2013-01-01T00:00:00Z